Welcome to our dedicated page for CTS news (Ticker: CTS), a resource for investors and traders seeking the latest updates and insights on CTS stock.
CTS Corporation designs and manufactures products that Sense, Connect and Move, including sensors, actuators and electronic components. The company supplies engineered products from operations in North America, Europe and Asia to aerospace & defense, industrial, medical and transportation customers.
Recurring CTS news centers on quarterly and annual results, demand across diversified end markets and transportation, margin and cash-flow commentary, guidance, dividends, share repurchase authorizations, investor presentations and management or board updates.
CTS (NYSE: CTS) announced that its Board of Directors declared a cash dividend of $0.04 per share on common stock.
The dividend is payable on July 24, 2026 to shareholders of record as of the close of business on June 26, 2026.
CTS (NYSE: CTS) reported first-quarter 2026 results with sales of $139 million, up 11% year-over-year, and diversified end-market sales up 18%. Net income was $17 million (12.4% of sales); diluted EPS was $0.59. Adjusted gross margin improved to 39.5% and adjusted EBITDA margin to 23.0%. Operating cash flow was $17.3 million. CTS narrowed full-year 2026 sales guidance to $560–$580 million and adjusted diluted EPS to $2.35–$2.45, and noted it cannot reconcile forward-looking non‑GAAP measures to GAAP.
CTS Corporation (NYSE: CTS) will release first quarter 2026 earnings at approximately 8:00 a.m. ET on Wednesday, April 29, 2026. A management conference call is scheduled for 10:00 a.m. ET on April 29, 2026, with registration required for dial-in details.
A live audio webcast will be available from the Investors section of CTS Corporation's website and archived there for one year.
CTS (NYSE: CTS) announced a cash dividend of $0.04 per share, payable April 24, 2026, to shareholders of record at the close of business on March 27, 2025.
The Board declared the dividend on February 12, 2026; the payment and record dates are specified for shareholder payment logistics.
CTS (NYSE: CTS) reported fourth quarter and full‑year 2025 results with continued diversification and margin expansion. Q4 sales were $137 million (+9% YoY); full‑year sales were $541 million (+5% YoY). Net income rose to $65 million for 2025 and diluted EPS was $2.19. Adjusted gross margin expanded 150 bps to 38.5% for the year. Management issued 2026 guidance of $550–$580 million sales and adjusted diluted EPS of $2.30–$2.45.
CTS Corporation (NYSE: CTS) will release fourth quarter and full-year 2025 earnings at approximately 8:00 a.m. ET on Tuesday, February 10, 2026. A conference call with management is scheduled for 10:00 a.m. ET the same day.
Registration is required to obtain dial-in and conference ID; a live audio webcast will be available on the company Investors site and archived for one year.
CTS Corporation (NYSE: CTS) announced that President and CEO Kieran O’Sullivan will present at the 28th Annual Needham Growth Conference on January 13, 2026 at the Lotte New York Palace Hotel. The presentation begins at 4:30 PM Eastern Time.
A live webcast will be available via the company website investor section and the conference link, and the webcast replay will remain available on the conference site for 90 days after the presentation.
CTS (NYSE:CTS) announced the appointment of Pratik Trivedi as Chief Operating Officer, effective December 5, 2025. Mr. Trivedi is currently Senior Vice President at CTS and previously held leadership roles at Eaton and Cummins, bringing described industry experience to the COO role. The company said the appointment supports execution of its growth strategy, with Chairman and CEO Kieran O'Sullivan expressing confidence in Trivedi's leadership and track record since joining CTS.
CTS Corporation (NYSE: CTS) declared a $0.04 per share cash dividend payable on Jan 23, 2026 to shareholders of record on Dec 26, 2025. The board also authorized a new $100 million share repurchase program to replace the February 2024 plan.
The repurchase program has no set expiration date and permits buys in the open market or via privately negotiated transactions; timing and amounts will depend on market conditions and other factors.
CTS (NYSE: CTS) announced the appointment of Kimberly Banks MacKay to its Board of Directors, effective November 5, 2025. She will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee.
Ms. MacKay has over 30 years of experience in multinational companies and currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services. She also holds board and committee roles with the Community Foundation of New Jersey and BAYADA Home Health Care. Company leadership said her healthcare and global business experience supports CTS’s focus on growth, end-market diversification, and its products that sense, connect and move.